Healthcare investment specialist ARCHIMED has the expertise, experience, enthusiasm and financial strength to fully back Instem’s ambitions.
PHILADELPHIA, PA – (BUSINESS WIRE) – November 27, 2023 - Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it has been acquired by ARCHIMED as an integral part of the company’s mission to enable clients to bring their life enhancing products to market faster.
September 28, 2023 - New Software Module Introduced to Support the Latest Regulatory-approved Carcinogenic Potency Categorization Approach (CPCA)
May 15, 2023 - New powerful technology and data sharing suite provides a range of translational science solutions
November 2, 2022 - New functionality along with Enhanced Models to Deliver More Efficient and Comprehensive Predictions in Chemical Safety
May 10, 2022 - Instem Secures Portion of €2.5m Grant as Member of Research Consortium Investigating the Mutagenicity of N-nitrosamines
Proud to be Presenting at Extractables & Leachables Summit
January 17 - 19, 2024
'Applications of computational methods in the assessment of extractables and leachables'
Dr. Candice Johnson, Senior Research Scientist
Exhibiting at the 40th Annual Meeting of the Japanese Society of Toxicologic Pathology
January 23 - 24, 2024
Curian (Shinagawa General Citizen's Hall), Tokyo, Japan
Solution Areas: Preclinical Study Management, SEND